Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emami Ltd Capital/Financing Update 2022

Jul 21, 2022

61637_rns_2022-07-21_4ae061f9-ace8-4bd3-a8d4-e1a96cb84395.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Date: zi- July 2022

The Secretary The National Stock Exchange of India Ltd. Exchange Plaza, Plot No. C/1, G. Block Bandra Kurla Complex, Bandra (E) Mumbai: 400051 Scrip Code: EMAMILTD

The Secretary BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai: 400001 Scrip Code: 531162

Dear Sirs,

Re: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015

This is to inform you that the Company has entered into an agreement for subscription of 4,522 Equity Shares of Cannis Lupus Services India Private Limited, equivalent to 30% of shareholding in the company.

The details required under Regulation 30 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 alongwith is enclosed as Annexure -1.

Further, pursuant to Regulation 30(8) of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 the enclosed Disclosures will be made available on the Company's website at: http://www.emamiltd.in/investor-info/

Kindly take the same on record.

Thanking you, Yours faithfully, For Emami Limited

L ---

A. K. Joshi Company Secretary & VP- Legal Encl. As above.

Annexure -1

Disclosure under sub-para (1) [i.e. Acquisition(s) (including agreement to acquire)] of Para (A) of Part (A) of Schedule III to the Regulation 30 SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

SlNo Particulars
A of
the
entity
Name
target
Private
Limited
Cannis
Lupus
Services
India
B Whether
the
acquisition
would
fall
within
related
transaction(s)
and
party
promoter/
whether
the
group/
promoter
group
companies
have
any
entity
being
interest
the
in
acquired?
If
of
nature
yes,
and
details
thereof
interest
whether
the
and
is
same
length";
done
at"
arms
Company
The
related
Investee
is not
party.
a
group/
promoter/
of
the
None
promoter
group
being
have
the
entity
companies
interest
in
any
acquired.
C which
the
Industry
entity
to
being
acquired
belongs;
Ayurvedic/
herbal
offering
Pet
segment
care
Ball
"Fur
remedies
for
under
the
brand
pets
Story".
D of
Objects
effects
and
acquisition
line
with
Emami'
Investment
is in
s strategy
E Brief
details
of
any
governmental
regulatory
or
approvals
required
for
the
acquisition;
None
F period
for
Indicative
time
completion
of
the
acquisition;
July,
2022
21st
G of
Nature
consideration
-
whether
cash
consideration
details
of
share
and
swap
or
the
same;
Cash
H Cost
of
acquisition
the
or
which
the
shares
price
at
acquired;
are
mutually
agreed
valuation,
price
of
It
is
per
as
of
disclosed
due
shares
has
been
to
not
reasons
confidentialit):-.-i-:-_?